AstraZeneca
AZN
AZN
553 hedge funds and large institutions have $20.4B invested in AstraZeneca in 2019 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 181 increasing their positions, 186 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 545 → 553 (+8)
0.18% less ownership
Funds ownership: 35.06% → 34.88% (-0.18%)
3% less repeat investments, than reductions
Existing positions increased: 181 | Existing positions reduced: 186
Holders
553
Holding in Top 10
7
Calls
$104M
Puts
$72.7M
Top Buyers
| 1 | +$154M | |
| 2 | +$153M | |
| 3 | +$93.4M | |
| 4 |
Goldman Sachs
New York
|
+$70.6M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$60M |
Top Sellers
| 1 | -$340M | |
| 2 | -$76.8M | |
| 3 | -$61.2M | |
| 4 |
Renaissance Technologies
New York
|
-$55.9M |
| 5 |
EIP
Epoch Investment Partners
New York
|
-$44.4M |